Article Menu
Need Help?
No Article Versions Notes Found
Cite
González-López, T.J.; Vázquez, L.; Flores, T.; San Miguel, J.F.; GarcÃa-Sanz, R. Long-Term Reversibility of Renal Dysfunction Associated to Light Chain Deposition Disease with Bortezomib and Dexamethasone and High Dose Therapy and Autologous Stem Cell Transplantation. Clin. Pract. 2011, 1, e95. https://doi.org/10.4081/cp.2011.e95
González-López TJ, Vázquez L, Flores T, San Miguel JF, GarcÃa-Sanz R. Long-Term Reversibility of Renal Dysfunction Associated to Light Chain Deposition Disease with Bortezomib and Dexamethasone and High Dose Therapy and Autologous Stem Cell Transplantation. Clinics and Practice. 2011; 1(4):e95. https://doi.org/10.4081/cp.2011.e95
Chicago/Turabian StyleGonzález-López, Tomás J., Lourdes Vázquez, Teresa Flores, Jesus Fernando San Miguel, and Ramon GarcÃa-Sanz. 2011. "Long-Term Reversibility of Renal Dysfunction Associated to Light Chain Deposition Disease with Bortezomib and Dexamethasone and High Dose Therapy and Autologous Stem Cell Transplantation" Clinics and Practice 1, no. 4: e95. https://doi.org/10.4081/cp.2011.e95
APA StyleGonzález-López, T. J., Vázquez, L., Flores, T., San Miguel, J. F., & GarcÃa-Sanz, R. (2011). Long-Term Reversibility of Renal Dysfunction Associated to Light Chain Deposition Disease with Bortezomib and Dexamethasone and High Dose Therapy and Autologous Stem Cell Transplantation. Clinics and Practice, 1(4), e95. https://doi.org/10.4081/cp.2011.e95
